Organto Foods (TSX-V: OGO) (OTC: OGOFF) has signed an agreement to sell its Colombian subsidiary Medicannabis S.A.S. to Xebra Brands for a combination of shares, cash and forgiveness of debt. Medicannabis is focused on the development of medicinal cannabis.
Canntab Therapeutics (CSE: PILL.CN) (OTCQX: CTABF) (FRA: TBF1.F), an innovator in cannabinoid and terpene blends in hard pill form for therapeutic application, has signed a binding letter of intent to establish a joint venture with World Class Extractions (CSE: PUMP). Under the terms, WCE will install certain extraction and processing systems at Canntab’s production facility in Markham, Ontario.
Inner Spirit Holdings (CSE: ISH) announced the opening for its newest franchise retail cannabis store in Southeast Calgary’s Penbrooke community. In addition, the company said that it has received cannabis retail store licences from Alberta Gaming, Liquor and Cannabis for a franchise location in Sexsmith, Alberta and from the British Columbia Liquor and Cannabis Regulation Branch for a franchise location in West Kelowna, British Columbia.
Target Group (OTCQB: CBDY) announced that its subsidiary Canary RX has been granted licenses to cultivate, process and sell cannabis pursuant to the Cannabis Act. Located just outside of Toronto, Canary RX will begin cultivating cannabis in its 44,000 square foot facility, producing 3600 kilograms annually.
“We are disappointed that Aleafia has chosen to terminate its Agreement with Aphria Inc. The Company had every intention of fulfilling its obligations under the Agreement. As a large shareholder of Aleafia, Aphria made good faith efforts to ensure continuation of the Agreement understanding it was in the best interest of all parties involved. However, the termination of this legacy Agreement frees up significant supply allowing the Company to service its brands that are in high-demand across the country.”
Supreme Cannabis (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) has announced that its premium wellness brand and a multi-licensed processor and distributor Blissco Cannabis has received licensing approval from Health Canada for the sale of cannabis oils from its facility in Langley, British Columbia. The license allows Blissco to sell full spectrum cannabidiol (CBD) oil products.